ABOUT USdot CONTACTdot LOG IN

Archives for the 'news1' Category

GE Healthcare to Surreptitiously Monitor the Elderly through QuietCare Collaboration

GE Healthcare has entered into a distribution and technology collaboration with Living Independently Group (LIG). QuietCare, LIG’s principal product, is a “behavioral remote patient monitoring system” that uses wireless sensors to track the patterns of […]

26 September 2008 | Blog, news1, feature1 | No Comments

GI Dynamics’ EndoBarrier Could Disrupt Gastric Bypass Surgery Market

According to the American Society for Bariatric Surgery, doctors perform 140,000 gastric bypass surgeries in the United States each year. The most common types are Roux-en-Y gastric bypass and Laparoscopic Adjustable Gastric Banding. About 1% of […]

22 September 2008 | Blog, news1, feature2 | No Comments

[Video Profile] Arterial Remodeling Technologies

Arterial Remodeling Technologies (ART) is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. ART’s bioresorbable stents provide the requisite mechanical scaffolding to resist initial recoil . […]

18 September 2008 | Blog, Member Spotlight, news1, feature1 | No Comments

Biolase: Checking In on the Turnaround

In February, I reported that a turnaround at Biolase was underway. Improved relations with Henry Schein, a key distributor, were largely responsible for the upturn. The company achieved fourth-quarter sales of more than $20 million - […]

18 September 2008 | Blog, news1, feature2 | No Comments

With MTX-100, BSD Medical Goes Head-to-Head with RF Ablation Technologies

BSD Medical, a developer of microwave systems used to treat cancer, has received FDA 510(k) clearance for its MicroThermX-100 Microwave Ablation System (MTX-100). MTX-100 is indicated for use in the ablation of soft tissue. The device […]

15 September 2008 | Blog, news1 | No Comments

What’s Next for NexMed?

After NexMed announced it would shelve its previously filed NDA for a toe nail fungus (TNF) treatment following disappointing Phase III clinical results, shares of the company slid to their lowest point in 13 years. In a […]

11 September 2008 | Blog, news1 | 3 Comments

[Device Profile] Long Term Data Supports Use of Powerlink

An abdominal aortic aneurysm (AAA) is a weakening of the wall of the aorta (the largest artery in the body), resulting in a balloon-like enlargement. If left untreated, the aorta will continue to enlarge and […]

8 September 2008 | Blog, news1 | 3 Comments

[Video Profile] Interview with Thomas Harold, Founder & CEO of ScyFIX

Age-Related Macular Degeneration (AMD) is the leading cause of blindness in persons over 50 throughout the western hemisphere. But despite the prevalence and severity of the disease, there is no approved treatment for over 90% […]

2 September 2008 | Blog, Member Spotlight, news1, feature1 | No Comments

NexMed Gets Nailed, Stock Price Derails

On Tuesday, NexMed announced that it would shelve its previously filed NDA for an onychomycosis treatment (NM100060) following disappointing Phase III clinical results. Onychomycosis, or toenail fungus, affects six to eight percent of the adult U.S. […]

28 August 2008 | Blog, news1 | 2 Comments

[Video] POM Wonderful: Seriously Profitable Science-Backed Marketing

POM Wonderful was founded by Stewart and Lynda Rae Resnick, who purchased a 100-acre pomegranate orchard in 1987. The company launched its namesake juice in 2002. From 2003 to 2006, annual sales climbed from $12 million […]

26 August 2008 | Blog, news1, Video, feature2 | No Comments

Search

Navigation

Meta

Archives

Seeking Alpha Certified
Equities Building Research Building Enterprises Building Resources Building